Stay updated with breaking news from Prashant Tapse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Analysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which comprises many niche biopharma products
BENGALURU: Shares of Adani Ports and Special Economic Zone, India’s largest private port operator, dropped 3.7% in...
The issue of SBFC Finance comprises fresh equity issue of Rs 600 crore and an offer for sale (OFS) of Rs 425 crore, while Concord Biotech is completely an OFS of 2.09 crore equity shares up, aggregating up to Rs 1,551 crore.
Shares of India's Mahindra and Mahindra fell nearly 7% on Thursday after the conglomerate's stake purchase in private lender RBL Bank raised concerns about the rationale of its capital allocation...